The Past Three Years for Fennec Pharmaceuticals (NASDAQ:FENC) Investors Has Not Been Profitable

Yahoo FinanceOct 1 06:35 ET

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswireSep 5 06:56 ET

H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsAug 22 06:31 ET · Ratings

Buy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK's Long-Term Growth Potential

TipRanksAug 22 06:18 ET · Ratings

Express News | Fennec Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $13 From $15

ReutersAug 22 06:05 ET

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This Year

Yahoo FinanceAug 21 06:25 ET